Literature DB >> 9043906

Sperm quality in Hodgkin's disease versus non-Hodgkin's lymphoma.

A Botchan1, R Hauser, R Gamzu, L Yogev, J B Lessing, G Paz, H Yavetz.   

Abstract

The study was conducted to determine the deleterious effect of lymphoma disease on spermatogenesis and to evaluate the possibility that the disease is mediated primarily by inherent mechanisms in Hodgkin's disease and non-Hodgkin's lymphoma patients. A total of 89 patients with lymphoma disease (Hodgkin's and non-Hodgkin's) were referred for sperm preservation prior to adjuvant treatments. A comparison was made of pre- and post-thaw sperm quality between lymphoma patients and healthy volunteers who applied for sperm donation. This was followed by further assessment of the differences between patients with Hodgkin's disease and non-Hodgkin's lymphoma in terms of sperm variables, clinical parameters and blood hormone concentrations. It was found that patients with lymphoma disease had significantly impaired pre-freeze and post-thaw sperm quality compared with that of healthy volunteers. Patients with non-Hodgkin's lymphoma had spermatozoa of higher quality than patients with Hodgkin's disease. No differences were found in the clinical or hormonal parameters between these two groups. As expected, reduced testicular size and abnormal testicular consistency were correlated with decreased sperm quality. The mere presence of cancer disease has a direct negative effect on spermatogenesis, which is probably not related to incidental side-effects. A variable degree of impairment should be expected with different categories of cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9043906     DOI: 10.1093/humrep/12.1.73

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  Reproductive patterns and non-Hodgkin lymphoma risk in Danish women and men.

Authors:  Morten Frisch; Bo V Pedersen; Jan Wohlfahrt; Henrik Hjalgrim; Robert J Biggar
Journal:  Eur J Epidemiol       Date:  2006-10-18       Impact factor: 8.082

2.  Characteristics of cryopreserved semen from men with lymphoma.

Authors:  J Hallak; A M Mahran; A Agarwal
Journal:  J Assist Reprod Genet       Date:  2000-11       Impact factor: 3.412

3.  Preservation of sperm of cancer patients: extent of use and pregnancy outcome in a tertiary infertility center.

Authors:  Amnon Botchan; Shiri Karpol; Ofer Lehavi; Gedalia Paz; Sandra E Kleiman; Leah Yogev; Haim Yavetz; Ron Hauser
Journal:  Asian J Androl       Date:  2013-03-25       Impact factor: 3.285

4.  Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in EORTC-GELA Lymphoma Group trials.

Authors:  Marleen A E van der Kaaij; Natacha Heutte; Jannie van Echten-Arends; John M M Raemaekers; Patrice Carde; Evert M Noordijk; Christophe Fermé; José Thomas; Houchingue Eghbali; Pauline Brice; Caroline Bonmati; Michel Henry-Amar; Hanneke C Kluin-Nelemans
Journal:  Haematologica       Date:  2009-10-22       Impact factor: 9.941

5.  FISH and tips: a large scale analysis of automated versus manual scoring for sperm aneuploidy detection.

Authors:  Guillaume Martinez; Pierre Gillois; Marine Le Mitouard; Rémy Borye; Camille Esquerré-Lamare; Véronique Satre; Louis Bujan; Sylviane Hennebicq
Journal:  Basic Clin Androl       Date:  2013-12-01

6.  Dysregulation of Key Proteins Associated with Sperm Motility and Fertility Potential in Cancer Patients.

Authors:  Manesh Kumar Panner Selvam; Renata Finelli; Saradha Baskaran; Ashok Agarwal
Journal:  Int J Mol Sci       Date:  2020-09-15       Impact factor: 5.923

7.  Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy.

Authors:  C E Kiserud; A Fosså; T Bjøro; H Holte; M Cvancarova; S D Fosså
Journal:  Br J Cancer       Date:  2009-01-20       Impact factor: 7.640

8.  Semen cryopreservation, utilisation and reproductive outcome in men treated for Hodgkin's disease.

Authors:  F H Blackhall; A D Atkinson; M B Maaya; W D J Ryder; G Horne; D R Brison; B A Lieberman; J A Radford
Journal:  Br J Cancer       Date:  2002-08-12       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.